<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887547</url>
  </required_header>
  <id_info>
    <org_study_id>Fattori2</org_study_id>
    <nct_id>NCT02887547</nct_id>
  </id_info>
  <brief_title>Biological Markers Evaluation of Accelerated Tooth Movement</brief_title>
  <official_title>Biomarkers Expression in Gingival Crevicular Fluid and Accelerated Tooth Movement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gingival Crevicular Fluid samples will be collected using periopapers after accelerated tooth&#xD;
      movement technique, results will be assessed with biomarkers levels done using ELISA Assays&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this prospective study, 22 individuals were selected, with skeletal discrepancies&#xD;
      randomly divided into two groups: 1 - accelerated tooth movement technique (ATMT) and 2 -&#xD;
      Control.&#xD;
&#xD;
      Orthodontic records done in two times, initial and preoperative; Gingival Crevicular Fluid&#xD;
      samples will be collected using periopapers in 7 times (1, 2, 7, 14, 28 days and after space&#xD;
      closure- end of orthodontic treatment movement activation).&#xD;
&#xD;
      Flapless cortical perforations will be made in ATMT Group after dental extraction. Surgical&#xD;
      protocol will be flapless to preserve periodontal health.&#xD;
&#xD;
      After extraction space closure, results will be assessed by clinical effects with biological&#xD;
      markers levels:&#xD;
&#xD;
      CCL3/MIP-1 alpha, CCL5/RANTES, CXCL8/IL8, IL-1 alpha, IL-1 beta, IL6, TNF-alpha, TRANCE/RANK&#xD;
      L, OCN OPG IL-10 VEGF TGF-â„¬&#xD;
&#xD;
      Those biomarkers levels will be performed using ELISA Assays. After collecting data, the&#xD;
      results will be statistically analyzed using Shapiro-Wilk and, posteriorly, T-student or&#xD;
      Wilcoxon.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory Cytokines ad Chemokines Detection Assay</measure>
    <time_frame>8 months</time_frame>
    <description>Measure the different levels of listed cytokines and chemokines after starting the anterior retraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone remodeling markers in GCF samples</measure>
    <time_frame>8 monnths</time_frame>
    <description>Measure the different levels of resorption biomarkers and bone formation after starting the anterior retraction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Cytokine Measurements</condition>
  <condition>Orthodontic Space Closure</condition>
  <condition>Tooth Movement</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group, with traditional orthodontic mechanics for anterior retraction. Crevicular fluid will be collected during anterior retraction mechanics to identified biomarkers in the inflammatory process</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acceleration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group with micro-osteoperforation for accelerated tooth movement during anterior retraction, Crevicular fluid will be collected during anterior retraction mechanics to identified biomarkers in the inflammatory process</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>micro-osteoperforation</intervention_name>
    <arm_group_label>Acceleration</arm_group_label>
    <other_name>accelerated tooth movement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects ages 18-40 years old, in good general health, with adult complete&#xD;
             dentition, regardless of presence of third molars.&#xD;
&#xD;
          -  Indication for orthognathic surgery&#xD;
&#xD;
          -  Tooth extraction indication for orthodontic treatment&#xD;
&#xD;
          -  Do not smoke&#xD;
&#xD;
          -  Periodontal and teeth healthy&#xD;
&#xD;
          -  Do not use bisphosphonates or corticosteroids&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Surgically assisted rapid palatal expansion indication&#xD;
&#xD;
          -  Cleft lip and palate&#xD;
&#xD;
          -  Craniofacial syndrome&#xD;
&#xD;
          -  Mental disorder&#xD;
&#xD;
          -  Metabolic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liana Fattori, MS PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phd candidate</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Rino Neto</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>December 20, 2015</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2016</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>LIANA FATTORI ABATI</investigator_full_name>
    <investigator_title>MS, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

